Examkin

Soru

Zorluk: Çok zorBreast Disorders

A 54-year-old postmenopausal woman comes to the clinic to discuss the results of a recent breast biopsy. A routine screening mammogram performed two weeks ago demonstrated a new 8-mm cluster of fine, pleomorphic microcalcifications in the upper outer quadrant of her right breast. Physical examination reveals no palpable breast masses, nipple discharge, or overlying skin changes. Axillary lymph nodes are not palpable. She has no personal or family history of breast, ovarian, or colon cancer. She underwent a stereotactic core needle biopsy of the calcifications. The histopathology report reveals classic lobular carcinoma in situ (LCIS) without evidence of invasive disease or atypia. Which of the following is the most appropriate next step in management?

  1. A
    Initiation of daily tamoxifen therapy
  2. B
    Adjuvant radiation therapy to the right breast
  3. Surgical excisional biopsy of the right breast lesionCevap
  4. D
    Bilateral prophylactic mastectomy
  5. E
    Reassurance and repeat diagnostic mammography in 6 months

Cevap

Surgical excisional biopsy of the right breast lesion
The correct next step is a surgical excisional biopsy of the right breast lesion. Although classic lobular carcinoma in situ (LCIS) is considered a non-malignant marker of increased risk for future bilateral breast cancer rather than a true precursor lesion, finding it on a core needle biopsy (CNB) presents a specific clinical dilemma. CNB samples only a small portion of the suspicious area. Studies demonstrate that in 10% to 30% of cases where CNB yields LCIS, complete surgical excision of the lesion reveals concurrent ductal carcinoma in situ (DCIS) or invasive carcinoma that the needle missed. Because of this significant 'upgrade rate', standard clinical guidelines mandate that a core biopsy diagnosis of LCIS must be followed by an open surgical excisional biopsy to thoroughly evaluate the entire lesion and definitively rule out malignancy. Only after the excisional biopsy confirms that the lesion is purely LCIS (with no higher-grade pathology) can the patient be safely transitioned to long-term observation and chemoprevention strategies.

Adım Adım Çözüm

1
Analyze the patient's presentation and initial diagnostic findings.
The patient has a new cluster of microcalcifications that yielded classic lobular carcinoma in situ (LCIS) on a stereotactic core needle biopsy.
Establishing the initial pathology and the method of tissue sampling is required to determine the next step in the clinical pathway.
2
Identify the clinical significance of finding LCIS specifically on a core needle biopsy.
Core needle biopsies only sample a fraction of the lesion. There is a 10% to 30% risk of an 'upgrade' to concurrent ductal carcinoma in situ (DCIS) or invasive cancer that was missed by the needle.
Understanding the limitations of core needle biopsies dictates whether additional tissue sampling is needed.
3
Determine the definitive next step in management.
An open surgical excisional biopsy must be performed to remove the entire area of calcifications and rule out a more advanced, concurrent malignancy before deciding on long-term management.
Complete excision provides the final, definitive pathology required to safely recommend observation or pharmacological risk reduction.

Anahtar Kavram

Management of Lobular Carcinoma In Situ (LCIS) diagnosed on core needle biopsy requires surgical excision to rule out concurrent invasive disease.
Bu soruyu puanla

Konular

Breast Disorders

Bu konudan daha fazla soru